Manhattan Scientifics Inc (MHTX)

[ssc]

Old news, but a few key points worth mentioning since they are obviously responsible for the extremely weak ibx share price.

1) Results from 5 trial patients.

2) Still recruiting in an effort to get 10 or 15.

3) Hoping for results by end of 2022.

4) Reiteration of the BIG ONE: Results will help to determine whether or not to move forward (ie the finger in the wind).

So this tiny Phase I trial will take about 2 years, by which time cash will probably be needed, if not much sooner. If everything goes well, larger Phase II study (another 2 years or more and tons of dilution), then if that one goes well, Phase III (guess what? More years, more cash).

Apologies to current share holders, but you were way too early (thanks for the cash though; life is good in Tahoe). In spite of what a little birdie might have told you, cash is running out and massive dilution is on the way. Particularly bad since share price is at low level and apparently going lower.